Latest financial market updates and expert analysis
Analysis Ocugen has reaffirmed the regulatory timeline for its lead gene therapy, OCU400, even as the company’s shares continue to languish and a key shareholder vote on its capital structure drags...
BioNTech shares closed Friday at EUR 78.05, down 3.0% on the session, capping a bruising stretch for the Mainz-based vaccine...
Ocugen shareholders are being asked to look a long way down the road. The company’s pivotal Phase 3 trial of...
Xiaomi has put real money to work on its own stock, picking up 1.9 million B-shares according to media reports....
A hotter-than-expected US inflation reading has knocked silver off balance, with the metal ending Friday at $57.13 an ounce —...
BYD has picked up a five-star rating in the Euro NCAP crash test for its SHARK DMO pickup, a day...
Samsung Electronics shares rose 2.6% in Seoul on Thursday, but the gain says more about the mood on the Korean...
Moderna shares climbed 4.9% in the previous session, lifted by a higher price target and anticipation of key study data....
British competition authorities are considering whether to slap a “strategic market status” designation on Microsoft, a move that could reshape...
Vulcan Energy has handed investors two very different pieces of news in the space of a week, and the temptation...
For years, Plug Power was the cautionary tale of the hydrogen trade — a company that funded its ambitions by...
